Literature DB >> 19536120

Educating for personalized medicine: a perspective from oncology.

D R Parkinson1, J Ziegler.   

Abstract

The personalized-medicine concept represents the future of oncology medicine. New genomics technologies will characterize patients biologically in ways that will drive more efficient and effective cancer treatment. Yet the introduction of these technologies is disruptive to current practices in clinical oncology, as well as to current regulatory and reimbursement strategies. The efficient introduction of personalized medicine will require education in addition to behavioral and policy changes by the various involved stakeholders.

Entities:  

Mesh：

Year:  2009        PMID： 19536120     DOI： 10.1038/clpt.2009.76

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  3 in total

1.  Perceptions of Personalized Medicine in an Academic Health System: Educational Findings.

Authors:  Allison Vorderstrasse; Sara Huston Katsanis; Mollie A Minear; Nancy Yang; Tejinder Rakhra-Burris; Jason W Reeves; Robert Cook-Deegan; Geoffrey S Ginsburg; Leigh Ann Simmons
Journal:  J Contemp Med Educ       Date:  2015

2.  Targeted Therapy Database (TTD): a model to match patient's molecular profile with current knowledge on cancer biology.

Authors:  Simone Mocellin; Jeff Shrager; Richard Scolyer; Sandro Pasquali; Daunia Verdi; Francesco M Marincola; Marta Briarava; Randy Gobbel; Carlo Rossi; Donato Nitti
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

3.  Are disruptive innovations recognised in the healthcare literature? A systematic review.

Authors:  Viknesh Sounderajah; Vanash Patel; Lavanya Varatharajan; Leanne Harling; Pasha Normahani; Joshua Symons; James Barlow; Ara Darzi; Hutan Ashrafian
Journal:  BMJ Innov       Date:  2020-09-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.